1 Introduction to Research & Analysis Reports
1.1 Immune Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Cell Therapy Overall Market Size
2.1 Global Immune Cell Therapy Market Size: 2023 VS 2032
2.2 Global Immune Cell Therapy Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Immune Cell Therapy Players in Global Market
3.2 Global Companies Immune Cell Therapy Product & Technology
4 Immune Cell Therapy Companies Profiles
4.1 Adaptimmune
4.1.1 Adaptimmune Company Summary
4.1.2 Adaptimmune Business Overview
4.1.3 Adaptimmune Immune Cell Therapy Product Offerings & Technology
4.1.4 Adaptimmune Immune Cell Therapy R&D, and Plans
4.2 Altor Bioscience Corporation
4.2.1 Altor Bioscience Corporation Company Summary
4.2.2 Altor Bioscience Corporation Business Overview
4.2.3 Altor Bioscience Corporation Immune Cell Therapy Product Offerings & Technology
4.2.4 Altor Bioscience Corporation Immune Cell Therapy R&D, and Plans
4.3 Cellectis
4.3.1 Cellectis Company Summary
4.3.2 Cellectis Business Overview
4.3.3 Cellectis Immune Cell Therapy Product Offerings & Technology
4.3.4 Cellectis Immune Cell Therapy R&D, and Plans
4.4 Juno Therapeutics
4.4.1 Juno Therapeutics Company Summary
4.4.2 Juno Therapeutics Business Overview
4.4.3 Juno Therapeutics Immune Cell Therapy Product Offerings & Technology
4.4.4 Juno Therapeutics Immune Cell Therapy R&D, and Plans
4.5 Kite Pharma
4.5.1 Kite Pharma Company Summary
4.5.2 Kite Pharma Business Overview
4.5.3 Kite Pharma Immune Cell Therapy Product Offerings & Technology
4.5.4 Kite Pharma Immune Cell Therapy R&D, and Plans
4.6 Novartis
4.6.1 Novartis Company Summary
4.6.2 Novartis Business Overview
4.6.3 Novartis Immune Cell Therapy Product Offerings & Technology
4.6.4 Novartis Immune Cell Therapy R&D, and Plans
4.7 Takara Bio
4.7.1 Takara Bio Company Summary
4.7.2 Takara Bio Business Overview
4.7.3 Takara Bio Immune Cell Therapy Product Offerings & Technology
4.7.4 Takara Bio Immune Cell Therapy R&D, and Plans
4.8 Unum Therapeutics
4.8.1 Unum Therapeutics Company Summary
4.8.2 Unum Therapeutics Business Overview
4.8.3 Unum Therapeutics Immune Cell Therapy Product Offerings & Technology
4.8.4 Unum Therapeutics Immune Cell Therapy R&D, and Plans
5 Sights by Region
5.1 By Region - Global Immune Cell Therapy Market Size, 2024 & 2032
5.2 By Region - Global Immune Cell Therapy Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Immune Cell Therapy in United States
5.3.2 United States Immune Cell Therapy Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Immune Cell Therapy in Europe
5.4.2 Europe Immune Cell Therapy Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Immune Cell Therapy in China
5.5.2 China Immune Cell Therapy Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Immune Cell Therapy Market Size Markets, 2024 & 2032
6.2 T Cell Therapy
6.3 Natural Killer (NK) Cell Therapy
6.4 Other
7 Sights by Application
7.1 By Application - Global Immune Cell Therapy Market Size, 2024 & 2032
7.2 Stomach Cancer
7.3 Lung Cancer
7.4 Colorectal Cancer
7.5 Esophageal Cancer
7.6 Pancreatic Cancer
7.7 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
